Searching...Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details Pharmacy compounding of prescription drugs |
Sepracor, Inc
Pharmaceutical Manufacturer |
Venable LLP | |||
| Details Pharmacy compounding of prescription drugs |
AstraZeneca Pharmaceuticals LP
Pharmaceutical Manufacturer |
Venable LLP | |||
| Details Lobby the Congress on HR 1190 and S 1750. Lobby on issues pertaining to Medical Oncology and Community Cancer Centers in the United States. Lobby on issues pertaining to secondary insurance carrier... |
COMMUNITY ONCOLOGY ALLIANCE
|
MRS. DIANNE KUBE | |||
| Details Issues related to Hatch-Waxman Act and to U.S. Patent and Trademark Office Director accepting late filings in certain cases of unintentional delay |
THE MEDICINES COMPANY
|
KING & SPALDING LLP | |||
| Details Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislati... |
INTL. ACADEMY OF COMPOUNDING PHARMACISTS
|
PARRY, ROMANI, DECONCINI & SYMMS | |||
| Details Federal policy relating to formulary placement of generic drugs and biosimilars; and S. 2333, the Pandemic and All-Hazards Preparedness Act, Title V, Section 501, Improving Notification Procedures... |
APOTEX CORP.
|
in-house lobbying | |||
| Details Farm Bill |
Nadine Chatman Consulting Firm, LLC
|
in-house lobbying | |||
| Details Dod/VA Pharmacy Benefit Management |
Express Scripts Incorporated
Pharmacy Benefit Manager |
Henry Consulting Group | |||
| Details Drug Safety Issues related to bulk pharmacy compounding |
Dey, LP
Pharmaceutical company |
B & D Consulting | |||
| Details Issues related to Medicare Part D drug formularies. |
Forest Laboratories, Inc.
Pharmaceutical manufacturer. |
Arnold & Porter LLP | |||
| Details Educating policy makers regarding FDA clinical trials. |
NABI Bio Pharmaceuticals
Bio Pharmaceutical Manufacturer |
Wexler & Walker Public Policy Associates | |||
| Details Support legislation that would allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. |
THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK
|
in-house lobbying | |||
| Details Education of plasma derived therapies. |
Octapharma USA
plasma fractionation specialist |
Washington Strategic Consulting | |||
| Details Safe distribution of drug/biologics; flu vaccine |
FFF Enterprise
Health care company dealing with biopharmaceutical management and distribution, health informati... |
Washington Strategic Consulting | |||
| Details Lobby House and Senate regarding restricrtions placed on the sale of pseudoephedrine, ephedrine and DEA on regulatory issues related to the control of pseuroephedrine as well as other List 1 pharma... |
Novelty, Inc.
Distribution of over-the-counter pharmaceuticals. |
Van Fleet Associates, Inc. | |||
| Details Legislation before the U.S. Congress affecting over-the-counter pharmaceuticals; Control and diversion of Methamphetmine. |
American Council on Regulatory Compliance
Manufacturing and Distribution of Over-the-Counter Pharmaceutical Products |
Van Fleet Associates, Inc. | |||
| Details CFI's Office of Public Policy lobbied against the "Religious Education Week" resolution introduced by Senator Lindsey Graham and others. CFI lobbied in favor of a "Banned Books Week" resolution int... |
Center for Inquiry, Inc. Office of Public Policy
|
in-house lobbying | |||
| Details ***, no specific bill(s), Deep Vein Thrombosis awareness |
Sanofi-Aventis
Healthcare/Pharmaceutical |
TARPLIN, DOWNS & YOUNG, LLC | |||
| Details Drug reimbursement issues |
MGI Pharma
Pharmaceutical company |
Patton Boggs LLP | |||
| Details Legislation relating to influenza vaccine; pandemic planning; and general vaccine-related proposals |
Novartis Vaccines & Diagnostics Inc.
Research, manufacturing and sale of biotechnology products to improve human health |
The Duberstein Group Inc. | |||
| Details Medicare reimbursement. |
Sidley Austin, LLP (for Sepracor)
Sidley Austin, LLP (Law firm) for Sepracor (Research-based pharmaceutical company) |
PARRY, ROMANI, DECONCINI & SYMMS | |||
| Details Health Care and pharmaceutical issues. |
FERRING PHARMACEUTICALS - USA
Pharmaceuticals |
BUCHANAN INGERSOLL & ROONEY PC | |||
| Details Medicare, Medicaid, FDA |
AdvaMed
Medicaire and FDA |
Tarplin, Downs & Young, LLC | |||
| Details H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PR... |
Walgreen Company
|
in-house lobbying | |||
| Details ***, no specific bill(s), Deep Vein Thrombosis awareness |
Sanofi-Aventis
Healthcare/Pharmaceutical |
TARPLIN, DOWNS & YOUNG, LLC | |||
| Details HR 5243 to amend the Public Health Service Act provide for emergency distribution of influenza vaccine Vaccine Manufacturing and liability issues; HR 5122 FY07 DOD Appropriation Bill; HR 4939 Emerg... |
Norvartis Vaccines and Diagnostics, Inc. (NOVAD)
Vaccine and diagnostic manufacturing |
PodestaMattoon, Inc. | |||
| Details Anti-dumping provisions |
The Livingston Group, LLC (Timminco Limited)
Government and Public Relations Consultants |
PD Frazer Consulting, Inc. | |||
| Details Trade association relations, CMS reimbursement, Food and Drug Administration |
Berlex Inc.
Manufacturer and marketer of diagnostic imaging products |
K Street Associates, LLC | |||
| Details Issues related to corporate tax reform and extension of the R&D tax credit. Issues related to pharmaceutical reimbursement; Issues related to the expansion of Medicaid drug rebate; Issues related t... |
SANOFI-AVENTIS U.S. Inc.
|
RICCHETTI INCORPORATED | |||
| Details S515 - Patent Reform Act of 2009. Entire bill. |
Amgen
|
MR. MICHAEL L. TINER |